Supplementary Table 1 from Attenuation of microRNA-126 Expression That Drives CD34<sup>+</sup>38<sup>−</sup> Stem/Progenitor Cells in Acute Myeloid Leukemia Leads to Tumor Eradication

XLSX file - 9KB, Patient characteristics and stem cell frequencies: Patient characteristics and stem cell frequencies of samples used for miRNA expression profiling using microarray. Molecular aberrancy indicates the aberrancy as detected by routine molecular analysis of the patient at diagnosis. '-' indicates no abnormalities found in all molecular analysis tested (e.g. t(8;21), t(15;17), inv(16), NPM1, EVI1, CEBPA, and MLL). The fraction HSC within the CD34+ population indicates the CD34+CD38-ALDHhighLAPneg cells within the CD45+CD34+ cell compartment. For LSC the fraction of CD34+CD38-ALDHlow/dim cells were used. F, female; M, male; WBC, white blood cell count.